AEON – aeon biopharma, inc. class a (US:NASDAQ)
Stock Stats
News
AEON Biopharma, Inc. (NASDAQ: AEON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting
AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
AEON Biopharma, Inc. (NASDAQ: AEON) had its price target lowered by analysts at HC Wainwright from $6.00 to $5.00. They now have a "buy" rating on the stock.
AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Form 8-K AEON Biopharma, Inc. For: Oct 07
Form 4/A AEON Biopharma, Inc. For: Aug 31 Filed by: PALMISANO ROBERT J
Form 4 AEON Biopharma, Inc. For: Aug 31 Filed by: Sy Jennifer
Form 4 AEON Biopharma, Inc. For: Aug 31 Filed by: Carter Eric G
Form 4 AEON Biopharma, Inc. For: Aug 31 Filed by: FISCHER JOST
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.